Can Blood Gene Expression Predict Which Patients with Multiple Sclerosis Will Respond to Interferon?
Open Access
- 22 February 2005
- journal article
- perspective
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 2 (2) , e33
- https://doi.org/10.1371/journal.pmed.0020033
Abstract
Gene expression patterns from peripheral blood cells may be useful as biomarkers for monitoring MS progression and response to therapy, argue Kaminski and Achiron.Keywords
This publication has 22 references indexed in Scilit:
- Transcription-Based Prediction of Response to IFNβ Using Supervised Computational MethodsPLoS Biology, 2004
- Gene Microarray Analysis of Peripheral Blood Cells in Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Biologic role of interferon beta in multiple sclerosisZeitschrift für Neurologie, 2004
- Glatiramer acetate for the treatment of multiple sclerosisExpert Opinion on Pharmacotherapy, 2004
- Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activityAnnals of Neurology, 2004
- Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to diseaseHuman Molecular Genetics, 2003
- Expression profiling identifies responder and non‐responder phenotypes to interferon‐β in multiple sclerosisBrain, 2003
- Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitisNature Medicine, 2002
- The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating DiseaseScience, 2001
- In Vivo Activated T Lymphocytes in the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple SclerosisNew England Journal of Medicine, 1985